Advertisement
Advertisement
Trending on Urology Times
1
Eugene Pietzak, MD, on pembrolizumab plus BCG for BCG-naïve “very high risk” T1 NMIBC
2
Mina Fam, MD, highlights significance of tebipenem pivoxil approval for cUTI
3
Retrospective study suggests differences in OAB therapy persistence among older adults
4
The UroOnc Minute: Keeping Patients Engaged in Active Surveillance, With Lourdes Guerrios-Rivera, MD, MSc
5